CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Alitretinoin

Last Updated: May 6, 2011
Result type: Reports
Project Number: S0232
Product Line: Reimbursement Review

Generic Name: Alitretinoin

Brand Name: Toctino

Manufacturer: Actelion

Therapeutic Area: Eczema

Indications: Eczema

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: October 24, 2011

Recommendation Type: List with clinical criteria and/or conditions